For 2QFY2013, Lupin's net sales grew by 28.6% yoy to Rs.2,239cr, above
our expectation of Rs.2,058cr. However, the OPM for the quarter stood at
20.3%, higher than our estimate of 19.1%. The net profit came in at
Rs.290cr, higher than our expectation of Rs.270cr. We continue to
maintain our Buy view on the stock.
Better than expected numbers:
Lupin reported net sales of Rs.2,239cr, up 28.6% yoy, higher than our
estimate. The company's gross margin came in lower at 60.3%, ie lower
than the last corresponding period (65.7%). However, inspite of the
same, on the back of lower R&D expenses, the OPM came in at 20.3%,
higher than our expectation of 19.1% (but lower than 21.4% in 2QFY2012).
Inspite
of the robust operating profit growth the net profit grew only by 8.6%
yoy on account of higher taxation and interest expenditure; the net
profit for the quarter stood at Rs.290cr.
Outlook and valuation:
We expect Lupin's net sales to post a 19.3% CAGR to Rs.10,082cr and
earnings to report a 26.5% CAGR to Rs.31.1/share over FY2012-14E.
Currently, the stock is trading at 21.6x and 18.1x FY2013E and FY2014E
earnings, respectively. We maintain our Buy recommendation on the stock
with a target price of Rs.647.
No comments:
Post a Comment